Immunodominance of HLA-B27-restricted HIV KK10-specific CD8+ T-cells is not related to naïve precursor frequency [Letter] by Iglesias, Maria Candela et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/41044/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Iglesias, Maria Candela, Briceno, Olivia, Gostick, Emma, Moris, Arnaud, Meaudre, Céline, Price,
David, Ungeheuer, Marie-Noëlle, Saez-Cirion, Asier, Mallone, Roberto and Appay, Victor 2013.
Immunodominance of HLA-B27-restricted HIV KK10-specific CD8+ T-cells is not related to naïve
precursor frequency [Letter]. Immunology Letters 149 (1-2) , pp. 119-122.
10.1016/j.imlet.2012.10.002 file 
Publishers page: http://dx.doi.org/10.1016/j.imlet.2012.10.002
<http://dx.doi.org/10.1016/j.imlet.2012.10.002>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
Immunology Letters 149 (2013) 119– 122
Contents lists available at SciVerse ScienceDirect
Immunology  Letters
jou rn al hom epage: www.elsev ier .com/ locate / immlet
Immunodominance  of  HLA-B27-restricted  HIV  KK10-specific  CD8+ T-cells  is  not
related  to  naïve  precursor  frequency
Maria  Candela  Iglesias a,1,2, Olivia  Briceno a,1, Emma  Gostickb,  Arnaud  Moris a, Céline  Meaudre a,
David A.  Priceb,  Marie-Noëlle  Ungeheuer c, Asier  Saez-Ciriond,  Roberto  Mallone e, Victor  Appay a,∗
a INSERM UMR S 945, Infections and Immunity, Université Pierre et Marie Curie-Paris 6, Hôpital Pitié-Salpêtrière, Paris, France
b Institute of Infection and  Immunity, Cardiff University School of  Medicine, Heath Park,  Cardiff, Wales, UK
c Institut Pasteur, Investigation Clinique et Accès aux Ressources Biologiques, Paris, France
d Institut Pasteur, Unité  de Régulation des Infections Rétrovirales, Paris, France
e INSERM U986, DeAR Lab Avenir, Université Paris Descartes, Paris, France
a  r  t  i  c  l e  i  n f  o
Article history:
Received 28 June 2012
Received in revised form
26  September 2012
Accepted 1 October 2012
Available online 13 October 2012
Keywords:
CD8+ T-lymphocytes
HIV epitope
HLA-B27
Immunodominance
Naïve precursors
a  b  s  t  r a  c t
The factors that  determine the  immunodominance,  efficacy  and almost ubiquitous  presence  of CD8+ T-cell
responses to the  HLA-B27-restricted  HIV-1 p24 Gag-derived  KK10 epitope remain  to be  fully elucidated.
Here, we  show that  neither  the  precursor  frequency  nor  the  priming  capacity  of KK10-reactive  CD8+ T-
cells  within  the  naïve pool  differ substantially in comparison to other  specificities.  These data  implicate
alternative  mechanisms  in the  relative protection  conferred by  CD8+ T-cell responses  to this  epitope.
© 2012 Elsevier B.V. All rights reserved.
It is well established that the expression of certain HLA class
I molecules, such HLA-B27 and HLA-B57, is associated with pro-
longed AIDS-free survival in HIV-1 infection [1].  Furthermore, a
number of studies indicate that  CD8+ T-cell responses restricted
by such HLA molecules present superior functional properties (e.g.
proliferative capacity, HIV suppressive capacity and polyfunction-
ality), which may  render them more effective [2–4]. Nonetheless,
the mechanistic basis for the acquisition of protective attributes
within these CD8+ T-cell populations remains unclear.
A high frequency of antigen-specific precursors in  the naïve pool
may  confer both quantitative and qualitative advantages during
the generation of effective CD8+ T-cell responses. In addition to
the obvious numerical and kinetic benefits associated with a high
precursor frequency, greater repertoire diversity within such naïve
antigen-specific populations could provide a  rich foundation for
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the optimal selection and priming of high quality clonotypes. This
is important given the fundamental role of individual clonotypes
as determinants of efficacy within CD8+ T-cell responses to spe-
cific viral antigens [5–7].  Thus, in  theory at least, the dominance
and functional properties of HIV-specific CD8+ T-cell populations
could be influenced by the initial frequency of antigen-reactive
precursors [8].  In line with this hypothesis, recent studies in
murine models indicate that naïve precursor frequencies can vary
widely between T-cell populations with distinct antigen specifici-
ties; these differences, in turn, impact immunodominance patterns,
differentiation kinetics and functional efficacy [9–13]. Although
evidence in  humans is  scarce, it is reasonable to predict that
naïve precursor frequency may  similarly shape T-cell memory in
response to antigen challenge. Indeed, the widespread incidence
and dominance of CD8+ T-cell responses to  the Melan-A/MART-1
epitope EV10 in HLA-A2+ melanoma patients is thought to be asso-
ciated with a particularly high frequency of naïve antigen-reactive
precursors [14], which can be observed in the majority of HLA-
A2+ individuals [15–17].  Moreover, a recent study indicates that
the immunodominance pattern of HLA-A2-restricted HCV-specific
CD8+ T-cell responses can be determined by the frequency of naïve-
precursors reactive for HCV epitopes [18–20].
To tackle this hypothesis in the context of HIV-1 infection, we
evaluated the frequency and priming capacity of naïve CD8+ T
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Fig. 1. Antigen-reactive naïve CD8+ T-cell precursor frequencies in healthy donors. (A) Representative staining of KK10/HLA-B*2705 tetramer+ CD8+ T-cells in one uninfected
donor pre- and post-enrichment from 108 PBMCs. Percentages of tetramer+ cells within the total CD8+ T-cell population are indicated. (B) Representative CD45RA and CCR7
staining of total (gray) or KK10/HLA-B*2705 tetramer+ (black) CD8+ T-cells in one uninfected donor pre- and post-enrichment. (C)  Frequencies of antigen-reactive CD8+
T-cell precursors in healthy donors. The indicated genotype-matched tetramers were produced using the HLA-A*0201 (SL9 and EV10), HLA-B*0702 (IL9 and RL9) and HLA-
B*2705  (KK10) heavy chains. Statistical analyses were conducted using the Mann–Whitney U-test. (D) Representative stainings of EV10/HLA-A*0201 and KK10/HLA-B*2705
tetramer+ CD8+ T-cells after priming with peptide-pulsed autologous dendritic cells and in  vitro expansion for 20 days. Percentages of tetramer+ cells within the total CD8+
T-cell population are indicated. (E) Percentages of expanded tetramer+ CD8+ T-cells in HLA-A*0201+ and HLA-B*2705+ healthy donors.
-cells specific for HIV-derived epitopes. In  particular, we  compared
these parameters for the HLA-B27-restricted p24 Gag-derived epi-
tope KK10 (KRWIILGLNK263–272), which elicits protective CD8
+
T-cell responses, versus epitopes restricted by HLA-A2 (p17 Gag
SL977–85) and HLA-B7 (gp160 Env IL9843–851 and Nef RL977–85)
that are not associated with efficacious immunity. The HIV-specific
CD8+ T-cell response in HLA-B27+ individuals almost invariably tar-
gets the KK10 epitope [21–23]. These cells display potent effector
functions [24,25], and represent the prototypic effective CD8+ T-
cell response against HIV-1. To eliminate potentially confounding
effects related to the influence of HIV infection on priming and
precursor consumption in vivo,  all analyses were performed using
samples obtained from healthy HIV-seronegative donors, screened
for HLA-A*0201, HLA-B*0701 and HLA-B*2705.
Although the number of virus-reactive precursors in the total
pool of human T-cells is  generally low, their frequency can be
measured directly ex vivo in  peripheral blood [18–20].  Accord-
ingly, to quantify HIV-derived epitope-specific naïve CD8+ T-cell
precursors in healthy donors, we first enriched these cells from
samples of 108 peripheral blood mononuclear cells (PBMCs) using
genotype-matched peptide-HLA class I tetramers and magnetic
beads (Fig. 1A). Parallel analyses of Melan-A/MART-1 EV10-reactive
CD8+ T-cell precursors were conducted in HLA-A*0201+ donors.
Eight donors were analyzed for the HLA-B*2705 restricted KK10
epitope, necessitating to screen up to  102 healthy donors for
HLA-B*2705 (which is an infrequent allele). For  comparison, seven
donors were analyzed for the HLA-A*0201 restricted SL9 and HLA-
B*0701 IL9 epitopes, five for the HLA-B*0701 RL9 epitope, and
sixteen for the HLA-A*0201 restricted EV10 epitope. The naïve
phenotype of antigen-reactive precursors was verified by  flow
cytometry assessment of CD45RA, CCR7 and CD27 expression on
tetramer+ cells (Fig. 1B). Precursor frequencies were calculated
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according to recently published procedures [18].  The frequency
of EV10-reactive CD8+ T-cell precursors was consistently high
(>100 cells per million CD8+ T-lymphocytes), in line with previous
reports [18,19]. In contrast, however, the frequency of KK10-
reactive precursors was low (approximately 1 cell per million CD8+
T-lymphocytes) and not substantially different from those mea-
sured for other HIV epitope specificities (Fig. 1C).
In further experiments, we  analyzed the expansion of
antigen-reactive naïve CD8+ T-cells during in vitro priming with
peptide-pulsed autologous dendritic cells, which were generated
from PBMCs by  differentiation with GM-CSF and IL-4, then matured
with a cytokine cocktail composed of TNF-, IL-1,  PGE2 and IL-7
[26]. The percentages of CD8+ T-cells specific for KK10, SL9 or EV10
that expanded in vitro from healthy donor PBMC samples were
compared by  tetramer staining after 20 days (Fig.  1D).  The indi-
viduals tested for in vitro stimulation were selected on the basis
that they displayed both HLA-A*0201 and HLA-B*2705 alleles, in
order to compare HLA-A*0201 and HLA-B*2705 restricted T-cell
expansions in individual donors (n =  4) and thus avoid a  potential
bias associated with inter-donor variability. In line with the ex  vivo
measurements of precursor frequency, antigen-reactive CD8+ T-
cell percentages for KK10 and SL9 were equivalent after in vitro
expansion, and significantly lower than those for EV10 in the same
cultures (Fig. 1E).
Collectively, these results show that the frequency of KK10-
reactive CD8+ T-cell precursors in the naïve pool is not significantly
elevated relative to  other HIV specificities. It  will be  of interest
to see if the same finding applies also to other immunodomi-
nant CD8+ T-cell responses important for the control of HIV or
SIV replication (e.g. epitopes restricted by HLA-B5701 or HLA-
B5801 in humans, or  Mamu-B*08, Mamu-B*17 and Mamu-A*01 in
macaques). Nonetheless, our data indicate that the frequency of
the naïve precursors per se cannot explain either the acquisition of
superior functional attributes by  KK10-specific CD8+ T-cell popu-
lations or the almost universal immunodominance of this response
in HLA-B27+ individuals infected with HIV-1. Alternative explana-
tions for the observed immunodominance of this response may  be
related to the TCR affinity or  avidity of the naïve cells that  make
up the KK10 reactive precursor population. For a  still undeter-
mined reason, this might be particularly high. The relative rarity
of these cells in healthy donors precluded detailed analyses of
their clonotypic composition and functional attributes (e.g. TCR
avidity), thus leaving open the possibility that intrinsic features
of the KK10-reactive precursor population may  confer particular
advantages in vivo.  Interestingly, the number of epitope precur-
sors generated during antigen processing, or epitope abundance,
which is particularly high in  the case of KK10, has been proposed
to impact on CD8+ T-cell response hierarchies and play a  role in the
immunodominance of the KK10 specific response [27]. Upon prim-
ing, this parameter, together with the seemingly rapid kinetics of
KK10 epitope presentation [28], may  influence the KK10 specific
T-cell population avidity and clonality, thought to be key factors of
the functional efficacy of this population [24,29].  Eventually, these
features may  also play a role in the acquired capability of KK10-
specific CD8+ T-cells to escape suppression by regulatory T-cells,
as recently reported [30], thus supporting their expansion capacity
and immunodominance. Further studies will be  needed to reach an
exact understanding of the sophisticated mechanisms underlying
the selection and maintenance of the CD8+ T-cells that are required
for an effective immune response against HIV.
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